US Patent Issued on June 10 for "Inhibitors of NF kappa-B activity for treatment of diseases and disorders" (California Inventor)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,760, issued on June 10.

"Inhibitors of NF kappa-B activity for treatment of diseases and disorders" was invented by Rajendra Sahai Bhatnagar (Burlingame, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Peptides and methods of use thereof, are disclosed for use in treating various diseases and disorders, including inflammation, pain, oral mucositis, oral lesions, and cancer. The peptides modulate the activity of the transcription factor NF KappaB."

The patent was filed on Aug. 22, 2023, under Application No. 18/453,807.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1...